| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $191.4M | — | -4.4% |
| Cost of Revenue | $62.1M | — | -12.3% |
| Gross Profit | $129.3M | — | -0.1% |
| R&D Expense | $26.8M | — | +7.4% |
| SG&A Expense | $25.4M | — | +1.5% |
| Operating Income | -$12.5M | — | -178.9% |
| Pre-tax Income | -$10.6M | — | -1166.3% |
| Income Tax | $2.1M | — | +119.1% |
| Net Income | -$12.6M | — | -612.3% |
| EPS (Basic) | -$0.09 | — | -800.0% |
| EPS (Diluted) | -$0.09 | — | -800.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $252.6M | +9.1% | +33.2% |
| Short-term Investments | $105.3M | -17.3% | -37.1% |
| Accounts Receivable | $97.1M | +1.3% | -12.6% |
| Current Assets | $533.6M | +1.8% | -1.4% |
| Total Assets | $634.6M | +2.7% | -0.7% |
| Current Liabilities | $416.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.4M | — | +26.5% |
| Capital Expenditures | $548K | — | -77.0% |
| Investing Cash Flow | $9.1M | — | +222.5% |
| Financing Cash Flow | -$2.9M | — | +50.6% |
| Free Cash Flow | $14.9M | — | +51.5% |
| -1.0% |
| Total Liabilities | $422.4M | +3.7% | -1.7% |
| Stockholders' Equity | $212.2M | +0.8% | +1.3% |